Agricultural Solutions
Q1 2022
Sales in the Agricultural Solutions segment rose considerably compared with the first quarter of 2021. Volumes increased in all regions except North America; prices were above the prior-year quarter in all regions. Positive currency effects, especially from the U.S. dollar, also contributed to sales growth.
Volumes |
9.7% |
---|---|
Prices |
6.6% |
Portfolio |
–0.2% |
Currencies |
3.2% |
Sales |
19.4% |
Sales in Europe rose significantly, mainly as a result of increased volumes, especially for fungicides and herbicides. Higher prices also had a positive impact on sales. Negative currency effects, primarily from the Turkish lira, had an offsetting effect.
Sales in North America increased considerably, mainly due to positive currency effects. Price levels were significantly above the prior-year quarter, while volumes decreased slightly.
In Asia, sales rose strongly as a result of higher volumes, especially of herbicides and fungicides, primarily in China. Positive currency effects and increased prices contributed to the positive sales development as well.
Sales also rose considerably in the region South America, Africa, Middle East. This was mainly driven by increased volumes, especially for fungicides and field crop seeds. Positive currency effects, mainly from the Brazilian real, and higher price levels also had a positive impact on sales.
Income from operations (EBIT) before special items rose slightly compared with the first quarter of 2021 as a result of the sales increase. Higher fixed costs dampened the positive earnings development.
|
|
2022 |
2021 |
+/– |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales to third parties |
|
3,397 |
2,846 |
19.4% |
||||||||||
Income from operations before depreciation, amortization and special items |
|
1,036 |
971 |
6.7% |
||||||||||
Income from operations before depreciation and amortization (EBITDA) |
|
1,031 |
968 |
6.5% |
||||||||||
Depreciation and amortizationa |
|
168 |
164 |
2.2% |
||||||||||
Income from operations (EBIT) |
|
863 |
804 |
7.4% |
||||||||||
Special items |
|
–5 |
–3 |
–65.7% |
||||||||||
EBIT before special items |
|
868 |
807 |
7.6% |
||||||||||
Assets (March 31) |
|
17,238 |
16,546 |
4.2% |
||||||||||
Investments including acquisitionsb |
|
61 |
48 |
26.7% |
||||||||||
Research and development expenses |
|
237 |
216 |
9.9% |
||||||||||
|